Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •Abbreviations
- •Preface
- •1. Natural Products as Drug Candidates
- •1.1 Introduction
- •1.2 An array of natural products
- •1.2.1 Plant-derived natural products
- •1.2.2 Microbial natural products
- •1.3 Importance of analytical techniques
- •1.3.1 A glance at extraction techniques
- •1.3.2 Microbial culturing techniques
- •1.3.3 Outlook and perspectives in nanoparticles
- •1.4 Natural products as a guide in drug design and synthesis
- •1.5 Natural products as promising drug candidates
- •1.5.1 Antiviral drug candidates
- •1.5.2 Antiparasitic drug candidates
- •1.5.3 Neuroprotective agents
- •1.6 Conclusion
- •Keywords
- •References
- •2. Traditional Knowledge for Drug Discovery
- •2.1 Introduction
- •2.2 Databases on indian remedial flora, indigenous medicines, and phytochemicals
- •2.2.1 Cultural preservation
- •2.2.2 Sustainable practices
- •2.2.3 Biodiversity conservation
- •2.2.4 Health and medicine
- •2.2.5 Climate change adaptation
- •2.2.6 Interconnectedness and wisdom
- •2.3 History of traditional knowledge
- •2.3.1 Indigenous healing practices
- •2.3.2 Aboriginal dreamtime
- •2.3.3 Traditional agriculture
- •2.3.4 Traditional crafts
- •2.3.5 Indigenous cosmologies
- •2.3.6 Traditional music and dance
- •2.3.7 Traditional navigation
- •2.4 Traditional medicine in plant formulations
- •2.4.1 Ayurveda
- •2.4.2 Traditional chinese medicine
- •2.4.3 Indigenous healing practices
- •2.5 Drug discovery
- •2.6 Aspects of developing plant-based drugs
- •2.6.1 Selection criteria for plants
- •2.6.2 Plant material authentication
- •2.6.3 Extraction methods
- •2.6.4 Isolation and structure elucidation of bioactive components
- •2.6.5 Standardization of plant formulations
- •2.7 Conclusions
- •References
- •3. Herbal Healing: Plant-Based Natural Products
- •3.1 Introduction
- •3.2 Classification of secondary metabolites
- •3.2.1 Phenolic compounds
- •3.2.2 Terpenes
- •3.2.3 Alkaloids
- •3.3 History of natural products
- •3.4 Drug discovery from natural products
- •3.5 Drugs derived from the plants
- •3.6 Conclusions
- •Keywords
- •References
- •4. Natural Products with Antimicrobial Properties
- •4.1 Introduction
- •4.2 Plants as antimicrobial agents
- •4.3 Marine sources as antimicrobial agents
- •4.4 Antimicrobial products derived from microorganisms
- •4.5 Conclusions and future trends
- •Keywords
- •References
- •5. Natural Products with Immunomodulatory Properties
- •5.1 Introduction
- •5.2.1 Aloe vera (l.) burm.f. (family: asphodelaceae)
- •5.2.2 Andrographis paniculata (burm. f.) wall.ex.nees. (family: acanthaceae)
- •5.2.3 Acorus calamus l. (family: araceae)
- •5.2.4 Allium sativum l. (family: alliaceae)
- •5.2.5 Azadirachta indica a. juss. (family: meliaceae)
- •5.2.6 Argyreia speciosa (l.f.) sweet (family: convolvulaceae)
- •5.2.7 Bidens pilosa l. (family: asteraceae)
- •5.2.8 Baliospermum montanum (willd.) müll.arg. (family: euphorbiaceae)
- •5.2.9 Boerhaavia diffusa l. (family: nyctaginaceae)
- •5.2.10 Boswellia serrata roxb. excolebr. (family: burseraceae)
- •5.2.11 Camellia sinensis (l.) kuntze (family: theaaceae)
- •5.2.12 Capparis zeylanica l. (family: capparidaceae)
- •5.2.13 Calendula officinalis l. (family: asteraceae)
- •5.2.14 Chelidonium majus l. (family: papaveraceae)
- •5.2.15 Carica papaya l. (family: caricaceae)
- •5.2.26 Glycyrrhiza glabra l. (family: leguminosae)
- •5.2.27 Hypericum perforatum l. (family: hypericaceae)
- •5.2.28 Hippophae rhamnoides l. (family: elaeagnaceae)
- •5.2.29 Hydrastis canadensis l. (family: ranunculaceae)
- •5.2.30 Jatropha curcas l. (family: euphorbiaceae)
- •5.2.31 Mangifera indica l. (family: anacardiaceae)
- •5.2.32 Mollugo verticillata l. (family: molluginaceae)
- •5.2.33 Matricaria chamomilla l. (family: asteraceae)
- •5.2.34 Momordica charantia l. (family: cucurbitaceae)
- •5.2.35 Morinda citrifolia l. (family: rubiaceae)
- •5.2.36 Nigella sativa l. (family: ranunculaceae)
- •5.2.37 Nelumbo nucifera gaertn. (family: nymphaeceae)
- •5.2.38 Nerium oleander l. (family: apocynaceae)
- •5.2.39 Ocimum tenuiflorum l. (family: labiatae)
- •5.2.40 Premna tomentosa willd. (family: verbanaceae)
- •5.2.41 Plantago sp. (plantago major l. and plantago asiatica l.) (family: plantaginaceae)
- •5.2.42 Psoralea corylifolia l. (family: fabaceae)
- •5.2.43 Prunella vulgaris l. (family: lamiaceae)
- •5.2.44 Punica granatum l. (family: punicaceae)
- •5.2.45 Rhinacanthus nasutus (l.) kurz (family: acanthaceae)
- •5.2.46 Salvia officinalis l. (family: lamiaceae)
- •5.2.47 Tamarindus indica l. (family: leguminosae)
- •5.2.48 Tinospora cordifolia (willd.) miers (family: menispermaceae)
- •5.2.16 Centella asiatica (l.) urb. (family: umbelliferae)
- •5.2.17 Cichorium intybus l. (family: asteraceae)
- •5.2.18 Cryptolepis dubia (burm.f.) m.r. almeida (family: apocynaceae)
- •5.2.19 Citrus aurantiifolia (christm.) swingle (family: rutaceae)
- •5.2.20 Curcuma longa l. (family: zingiberaceae)
- •5.2.21 Desmodium gangeticum (l.) dc. (family: fabaceae)
- •5.2.22 Eclipta prostrata (l.) (family: asteraceae)
- •5.2.23 Phyllanthus emblica l. (family: euphorbiaceae)
- •5.2.24 Evolvulus alsinoides (l.) (family: convolvulaceae)
- •5.2.25 Ficus benghalensis l. (family: moraceae)
- •5.2.49 Terminalia chebula retz. (family: combretaceae)
- •5.2.51 Urtica dioica l. (family: urticaceae)
- •5.2.52 Withania somnifera (l.) dunal (cultivated var.) (family: solanaceae)
- •5.3 Traditional importance of research to society and researchers
- •5.4 Conclusion
- •Keywords
- •References
- •6. Natural Products with Anticancerous Properties
- •6.1 Introduction
- •6.2 Plant-derived anticancer compounds
- •6.2.1 Polyphenols
- •6.2.2 Flavanoids
- •6.2.3 Brassinosteroids
- •6.2.4 Vinca alkaloids
- •6.2.5 Taxanes
- •6.2.6 Campothecin derivatives
- •6.3 Microorganisms-based anticancer compounds
- •6.3.1 Primary metabolites
- •6.3.2 Secondary metabolites
- •6.4 Selected medicinal plants with anticancerous activities
- •6.4.1 Curcuma longa l.
- •6.4.2 Viscum album l.
- •6.4.3 Colchicum autumnale l.
- •6.4.4 Raphanus sativus l.
- •6.4.5 Tinospora cordifolia wild
- •6.4.6 Nigella sativa l.
- •6.5 Therapeutic enzymes
- •6.6 Future perspective
- •6.7 Conclusion
- •Keywords
- •References
- •7. Natural Products with Antiviral Properties
- •7.1 Introduction
- •7.2 Source of natural products with antiviral activity
- •7.3 Main components of natural products
- •7.3.1 Flavonoids
- •7.3.2 Polyphenols
- •7.3.3 Polysaccharides
- •7.3.4 Terpenoids
- •7.4 Mechanisms of action of natural compounds in viral infections
- •7.4.1 Direct antiviral effect
- •7.4.2 Anti-inflammatory effect in viral infections
- •7.4.3 Effect on autophagy process
- •7.6 Conclusions
- •Keywords
- •References
- •8. Approaches to Develop Drugs from Natural Products
- •8.1 Introduction
- •8.2 Scenario of drug discovery
- •8.3 Efficient drug discovery engines
- •8.4 Drug discovery approaches using plants
- •8.4.1 Plant selection for screening purpose
- •8.4.2 Authentication of plants
- •8.4.3 Types of molecular markers
- •8.5.1 Parallel approach
- •8.5.2 Sequential approach
- •8.6 Structure elucidation of isolated compounds
- •8.7 Biological screening of extracts/fraction/isolates
- •8.7.1 Cell culture-based assay
- •8.7.2 Dialysis
- •8.7.3 Microdialysis
- •8.7.4 Ultrafiltration
- •8.7.5 Chromatography
- •8.7.6 Ligand fishing
- •8.8 Limitations
- •8.9 Molecular modelling and np database
- •8.10 Future thrust
- •8.11 Conclusion
- •Keywords
- •References
- •9. Strategies for Isolation and Identification of Bioactive Molecules from Natural Sources
- •9.1 Introduction
- •9.2 Bioactive compounds in natural sources and their pharmacological properties
- •9.3.1 Selection of materials
- •9.3.3 Types and properties of solvent for extraction
- •9.4 Extraction methods (conventional and modern)
- •9.4.1 Conventional methods
- •9.4.2 Novel extraction methods
- •9.5 Concentration and purification of bioactive molecules using chromatographic techniques
- •9.5.1 Separation based on adsorption properties
- •9.5.2 Separation based on partition coefficient
- •9.5.3 Separation based on the molecular size
- •9.5.4 Separation based on ionic strength
- •9.5.5 Other modern separation techniques
- •9.6 Identification and characterization of bioactive molecules
- •9.6.1 Qualitative and quantitative techniques/chromatographic or nonchromatographic techniques
- •9.7 Conclusions
- •Keywords
- •References
- •10. Role of Omics in Natural Product-Based Drug Discovery
- •10.1 Introduction
- •10.2 Genomics and transcriptomics in natural product discovery
- •10.2.1 Case studies and examples of natural product discovery using genomics and transcriptomics
- •10.2.2 Limitations and challenges of using genomics and transcriptomics in natural product discovery
- •10.3 Proteomics and metabolomics in natural product discovery
- •10.3.1 Case studies and examples of natural product discovery using proteomics and metabolomics
- •10.4 Bioinformatics in natural product-based drug discovery
- •10.4.1 Role of bioinformatics in natural product-based drug discovery
- •10.4.2 The use of bioinformatics to predict and annotate natural product biosynthetic pathways, gene clusters, and metabolomics
- •10.7 Future perspectives and potential impact of omics in natural product-based drug discovery
- •10.9 Potential impact on drug discovery and development
- •10.10 Conclusion
- •Keywords
- •References
- •11. Natural Products from Endophytic Microorganisms
- •11.1 Introduction
- •11.1.1 Rational/why endophytes?
- •11.2 Diversity of endophytic microorganisms
- •11.2.1 Endophytic bacteria and endophytic actinomycetes
- •11.2.2 Endophytic fungi
- •11.3.1 ISolation methods
- •11.3.1.1.1 Dilution Plating
- •11.3.1.1.2 Direct Plating
- •11.3.2 Identification methods
- •11.4 Bioactive compounds from endophytic microorganisms
- •11.4.1 Antibiotics
- •11.4.2 Antifungal agents
- •11.4.3 Antimalarial agents
- •11.4.4 Antiviral agents
- •11.4.5 Anticancer agents
- •11.4.6 Antioxidants
- •11.5 Stepwise methods for natural product discovery from endophytic microorganisms
- •11.5.1 Plant selection rationale
- •11.5.2 Isolation and cultivation of endophytes
- •11.5.3 Characterization of endophytes
- •11.5.4 Extraction of natural products
- •11.5.5 Purification of natural products
- •11.6 Biosynthesis and strategies for the optimization of natural product discovery from endophytic microorganisms
- •11.6.1 Exploration of novel microbial sources
- •11.6.2 Metabolomics-guided discovery
- •11.6.3 Coculture
- •11.6.4 Genome mining
- •11.6.5 Modulation by ultraviolent irradiation
- •11.7 Future directions and challenges
- •11.7.1 Improving the efficiency and accuracy of screening methods
- •11.7.2 Enhancing the scalability and affordability of production methods
- •11.7.3 Ensure natural product safety and efficacy
- •11.8 Conclusions
- •References
- •12. Natural Products with Antidiabetic Properties
- •12.1 Introduction
- •12.2 Natural products that regulate glucose absorption
- •12.2.1 Serotonin-derived products
- •12.2.2 Butyl-isobutyl-phthalate from laminaria japonica
- •12.2.3 Bioactive compounds of allium cepa and allium sativum
- •12.2.4 Elatosides E and F of aralia elata
- •12.2.5 Bioactive compounds of bauhinia candicans and bauhinia forficate
- •12.3 Natural products that enhance insulin sensitivity
- •12.3.1 Astragalus membranaceus polysaccharides
- •12.3.2 Bioactive compounds of litchi chinensis
- •12.3.3 Bioactive compounds of fenugreek
- •12.3.4 Bioactive compounds of cinnamon
- •12.3.5 Bioactive compounds of gastrodia elata
- •12.3.6 Polysaccharides of dioscorea
- •12.3.7 Anthocyanins of blueberries
- •12.3.8 Bioactive compounds of psidium guajava
- •12.4.1 Gingerol from zingiber officinale
- •12.4.2 Curcumin from curcuma longa
- •12.4.3 Berberine
- •12.4.4 Capsaicin of pepper
- •12.4.5 Bioactive compounds of bitter melon
- •12.4.6 Ginsenosides of ginseng
- •12.4.7 Bioactive compounds of aloe vera
- •12.4.8 Quinides of coffee
- •12.4.9 Bioactive compounds of tinospora cordifolia
- •12.4.10 Bioactive compounds of pterocarpus marsupium
- •12.4.11 Eugenol of ocimum sanctum
- •12.4.12 Bioactive compounds of syzygium densiflorum
- •12.5 Clinical trials based on antidiabetic effects of natural products derived from plants
- •12.5.1 Gymnema sylvestre (gurmar)
- •12.5.2 Fenugreek (trigonella foenum-graecum)
- •12.5.3 Tea catechins
- •12.5.4 Coffee
- •12.5.5 Rosemary (rosmarinus officinalis)
- •12.6 Conclusion
- •12.7 Future scope
- •Keywords
- •References
- •13. Marine-Derived Natural Products with Anticancer Properties
- •13.1 Introduction
- •13.2 Marine bioactive compounds
- •13.3 Anticancer activity of marine plants
- •13.4 Anticancer agents from marine floras
- •13.5.1 Antioxidants
- •13.5.2 Immunomodulation and apoptosis
- •13.5.3 Nutritional values and anticancer effects
- •13.6 Nature and cancer chemotherapy
- •13.7 Marine organisms and cancer chemotherapy
- •13.8 Anticancer agents from marine floras
- •13.9 Marine plants
- •13.9.1 Macro algae (seaweed)
- •13.9.2 Mangroves and other higher plants
- •13.9.3 Cyanobacteria
- •13.9.4 Bacteria
- •13.9.5 Proteobacteria
- •13.9.6 Cyanobacteria
- •13.9.7 Actinomycetes
- •13.9.8 Marine fungi
- •13.9.9 Soft corals
- •13.9.10 Marine sponges
- •13.10 Anticancer bioactive antibiotics derived from marine sources
- •13.10.1 Polyphenols
- •13.10.2 Polysaccharides
- •13.10.3 Alkaloids
- •13.11 Other marine sources for anticancer compounds
- •13.11.1 Peptides
- •13.11.2 Plitidepsin
- •13.11.3 Trabectedin
- •13.11.4 Lurbinectedin
- •13.12 Marine natural products as anticancer drugs
- •13.13.1 Aquaculture/cultivation
- •13.13.2 Genetic engineering
- •13.13.3 Synthesis/semisynthesis/modification
- •13.14 Conclusions and future prospects
- •References
- •14. Natural Products as Novel Opportunities for Cathepsin Inhibitors
- •14.1 Introduction
- •14.2 Cysteine proteases (CPs)
- •14.2.1 Cathepsin
- •14.2.2 Structure and mechanism of action of cathepsins
- •14.3 NPs as cathepsins inhibitors
- •14.3.1 NPs From bacteria as cathepsin inhibitors
- •14.3.2 NPs from fungus as cathepsin inhibitors
- •14.3.3 NPs from marine organism as cathepsin inhibitors
- •14.3.4 NPs from plants as cathepsin inhibitors
- •14.4 Conclusion and future pespectives
- •Keywords
- •References
- •15. Phytoestrogens in Drug Discovery: A Focus on Mechanisms of Action and Safety Assessment
- •15.1 Introduction
- •15.2 Phytoestrogens and estrogen receptors
- •15.3 Nonestrogen receptor-mediated effects of phytoestrogens
- •15.3.1 Mitogen-activated protein kinase (MAPK) pathway
- •15.3.2 PI3K/AKT pathway
- •15.3.3 WNT pathway
- •15.3.4 G-protein-coupled estrogen receptor (GPER)
- •15.4 Structure–activity relationship (SAR) of phytoestrogens
- •15.4.1 Isoflavones
- •15.4.2 Lignans
- •15.4.3 Coumestans
- •15.4.4 Stilbenes
- •15.4.5 Diarylheptanoids
- •15.5 Comparing potency and efficacy of phytoestrogens on various pathways
- •15.5.1 Potency and efficacy of phytoestrogens on different pathways
- •15.5.2 Possible synergistic effects of phytoestrogens with other drugs
- •15.6 Effects of phytoestrogens on the human organs
- •15.7 Safety Assessment of phytoestrogens
- •15.7.1 Toxicity assays used to evaluate the safety of phytoestrogens
- •15.7.2 Potential adverse effects of phytoestrogens
- •15.8 Case study
- •15.8.1 Vaginal cellular differentiation assay
- •15.8.2 Changes in rat body weight
- •15.8.3 Changes in rats’ uterus weight
- •15.9 Current trends in phytoestrogen research
- •15.9.1 Publication trends
- •15.9.2 Analysis of contributing countries and contributing institutions
- •15.9.3 Analysis of contributing publishers and journals
- •15.9.4 Publication evolution and research areas
- •15.9.5 Limitations
- •15.10 Future directions
- •15.10.1 Exploration of unexplored plant sources
- •15.10.2 Understanding mechanisms of action
- •15.10.3 Synthesis of novel compounds
- •15.10.4 Development of SPERMs
- •15.10.5 Safety assessment
- •15.11 Conclusion
- •Keywords
- •References
- •16. Honey Bee Products with Antimicrobial Properties
- •16.1 Introduction
- •16.2 Honey
- •16.3 Bee bread (perga)
- •16.4 Bee pollen
- •16.5 Bee propolis
- •16.6 Conclusion
- •Keywords
- •References
- •17. Natural Products for the Prevention of Leaky Gut
- •17.1 Introduction
- •17.2 The physical and chemical barriers of the intestine
- •17.2.1 Thick mucus layer
- •17.2.2 Intestinal epithelial cells (IECS)
- •17.2.3 Intestinal junctional complexes
- •17.2.4 Lamina propria
- •17.2.5 Intestinal regulatory T cells
- •17.2.6 Intestinal alkaline phosphatase
- •17.2.7 Antimicrobial peptides
- •17.2.8 Lysozyme
- •17.3 Mechanistic view of factors leading to a leaky gut
- •17.3.1 Gut dysbiosis
- •17.3.2 Mucosal inflammation and oxidative stress
- •17.3.3 TJ disruption
- •17.3.4 Genetics
- •17.3.5 Drugs
- •17.4 Pathological implications of a leaky gut
- •17.5 Natural product improving gut microbial dysbiosis
- •17.5.1 Traditional herbs and polyherbal formulations managing gut micro flora
- •17.5.2 Phytocompounds in the management of intestinal barrier integrity through balancing gut microflora
- •17.6.1 Anti-inflammatory traditional medicine and plant extracts ameliorating intestinal mucosal injury
- •17.6.2 Plant active constituents preventing mucosal injury and oxidative damage
- •17.7 Traditional medicine and natural products upregulating the TJ proteins
- •17.7.1 Traditional medicine and herbal extracts promoting junction protein protection
- •17.7.2 Phytocompounds for junction protein protection
- •17.8 Natural products averting pathological conditions through maintaining intestinal barrier function
- •17.9 Conclusion
- •Keywords
- •References
- •18. Role of Natural Products in the Pharmacotherapy of Osteoporosis
- •18.1 Introduction
- •18.1.1 Effect of traditional chinese medicine (TCM)
- •18.1.2 Effect of malay traditional medicine
- •18.1.3 Antiosteoporotic agents extracted from plant sources
- •18.1.4 Treatment by different pigments
- •18.1.5 Other herbal sources
- •18.1.6 Natural plant-based alkaloids
- •18.1.7 Essential markers involved in bone formation and resorption for osteoporosis treatment
- •18.2 Conclusion
- •Keywords
- •References
- •19. Gel-Based Natural Therapeutics: Potential Alternatives to Traditional Drug Delivery Systems in Aquaculture
- •19.1 INtroduction
- •19.2 DDS
- •19.2.1 Water medication
- •19.3 Oral administration
- •19.3.1 Gavage

TABLE 12.1 (Continued)
Source of Natural Products Bioactive Compound Mode of Action Reference
Ficus benghalensis
Morus alba
Ilex paraguariensis 3,5-O-dicaffeoylquinic acid
Zingiber officinale
Nymphaea stellata
Pelargonidin and leucocyanidin
Methyl ursolate, betulinic acid,
kuwanon E, morusin, and cyclomorusin
Gingerol • Increasing insulin sensitivity Said et al. (2007)
Nymphayol • Improving the generation of pancreatic β cells Semwal et al. (2021)
• Stimulating pancreatic β cells for secreting insulin Kadam et al. (2019)
• Reducing lipid peroxidation and protecting pancreatic β cells Sharma et al. (2022)
• Elevation in the level of serum GLP-1 Semwal et al. (2021)
273

274
investigations and the mechanisms of action of natural products as agents for antidiabetic
treatment. To summarize, natural products, particularly those derived from plants, are
significant reservoirs of chemical compounds with diverse structures that may provide a
therapeutic option for managing type 2 diabetes through various mechanisms.
TABLE 12.2 Antidiabetic Natural Products and Their Chemical Structures
Natural Products Derived from Medicinal Plants Chemical Structures
Carthamus tinctorius (serotonin derivatives:
N-p-coumaryl serotonin, N-feruloyl serotonin)
Laminaria japonica (butyl-isobutylphthalate)
Allium sativum (allicin)
Capsicum sp. (capsaicin: 8-methyl-N-vanillyl-
6-nonenamide)
Blueberry (anthocyanins: Malvidin-3-glucoside,
malvidin-3-galactoside)
⏎
Various plant species (resveratrol:
3,5,40-trihydroxy-trans-stilbene)
Zingiber officinale (gingerol)

275
TABLE 12.2 (Continued)
Natural Products Derived from Medicinal Plants Chemical Structures
Pterocarpus marsupium (marsupsin, pterostilbene)
Curcuma longa (curcumin)
12.7 FUTURE SCOPE
Studies of naturally occurring chemicals have shown promising results in combating
diabetes. The rising prevalence of diabetes and the limitations of present treatments
underscore the need for innovative and effective therapeutic strategies. Finding effective
natural remedies for diabetes could proceed down various avenues. New antidiabetic
compounds will likely be discovered in as-yet-undiscovered natural deposits. In this
regard, metagenomics offers a potential approach. When it comes to creating safe and
effective medications, knowledge about the mechanism of action of natural products is
essential. Metabolomics, transcriptomics, and proteomics are needed to learn about the
mechanisms of action of these drugs. It has been discovered that natural component
combination therapy with antidiabetic medicines can boost the efficacy of both therapies
while decreasing the likelihood of unwanted side effects. Natural product efficacy and
safety must be established through clinical research. In the future, these substances will be
evaluated in carefully planned clinical trials. The potential exists in the field of precision
medicine for the use of natural products for tailored treatment approaches in patients with
diabetes. Natural compounds with antidiabetic properties have great potential as research
subjects for the discovery of new and improved treatments for diabetes.
KEYWORDS
• diabetes mellitus
• natural products
• antidiabetic properties
• herbal remedies
• hypoglycemic agents
• medicinal plants

276
REFERENCES
Abdel Raoof, G. F.; Mohamed, K. Y. Natural products for the management of diabetes. In: Studies in Natural
Products Chemistry. 1st edn. Elsevier B.V. 2018, Vol. 59. doi: 10.1016/B978-0-444-64179-3.00010-4
Aderonke Otunola, G.; Jide Afolayan, A. A review of the antidiabetic activities of ginger. In: Ginger Cultivation
and its Antimicrobial and Pharmacological Potentials. 2020, pp. 1–13. doi: 10.5772/intechopen.88899
Ahmad, A.; Ahmad, N.; Anis, M.; Faisal, M.; Alatar, A. A.; Abdel-Salam, E. M.; Meena, R. P.; Sivanesan, I.
Biotechnological advances in pharmacognosy and in vitro manipulation of pterocarpus marsupium roxb.
Plants. 2022, 11(3), 1–39. doi: 10.3390/plants11030247
Ajuwon, O. R.; Ayeleso, A. O.; Adefolaju, G. A. The potential of South African herbal tisanes, rooibos and
honeybush in the management of type 2 diabetes mellitus. Molecules. 2018, 23(12), 3207. doi: 10.3390/
molecules23123207
Akar, F.; Pektas, M. B.; Tufan, C.; Soylemez, S.; Sepici, A.; Ulus, A. T.; Gokalp, B.; Ozturk, K.; Surucu, H. S.
Resveratrol shows vasoprotective effect reducing oxidative stress without affecting metabolic disturbances
in insulin-dependent diabetes of rabbits. Cardiovasc. Drugs Ther. 2011, 25(2), 119–131. doi: 10.1007/
s10557-010-6255-7
Anand, A.; Chawla, J.; Mahajan, A.; Sharma, N.; Khurana, N. Therapeutic potential of epigallocatechin gallate.
Int. J. Green Pharm. 2017, 11(3), S364–S370.
Anand, V.; Manikandan, Kumar, V.; Kumar, S.; Pushpa; Hedina, A. Phytopharmacological overview of Psidium
guajava linn. Pharmacogn. J. 2016, 8(4), 314–320. doi: 10.5530/pj.2016.4.3
Arif, A.; Jia, J.; Willard, B.; Li, X.; Fox, P. L. Multisite phosphorylation of S6K1 directs a kinase phospho-code
that determines substrate selection. Mol. Cell. 2019, 73(3), 446-457.e6. doi: 10.1016/j.molcel.2018.11.017
Campos-Florián, J.; Bardales-Valdivia, J.; Caruajulca-Guevara, L.; Cueva-Llanos, D. Anti-diabetic effect of
Coffea arabica, in alloxan-induced diabetic rats. Emirates J. Sci. Food Agric. 2013, 25(10), 772–777. doi:
10.9755/ejfa.v25i10.16409
Cano-Marquina, A.; Tarín, J. J.; Cano, A. The impact of coffee on health. Maturitas. 2013, 75(1), 7–21. doi:
10.1016/j.maturitas.2013.02.002
Christiansen, C. B.; Gabe, M. B. N.; Svendsen, B.; Dragsted, L. O.; Rosenkilde, M. M.; Holst, J. J. The impact
of short-chain fatty acids on glp-1 and pyy secretion from the isolated perfused rat colon. Am. J. Physiol.
Gastrointest. Liver Physiol. 2018, 315(1), G53–G65. doi: 10.1152/ajpgi.00346.2017
Couturier, K.; Qin, B.; Batandier, C.; Awada, M.; Hininger-Favier, I.; Canini, F.; Leverve, X.; Roussel, A. M.;
Anderson, R. A. Cinnamon increases liver glycogen in an animal model of insulin resistance. Metab.: Clin.
Exp. 2011, 60(11), 1590–1597. doi: 10.1016/j.metabol.2011.03.016
Deokate, U.; Upadhye, M. Antioxidant potential of phytoconstituents with special emphasis on curcumin.
Ginger—Cultivation and Use. 2023, doi: 10.5772/intechopen.103982
Deyno, S.; Eneyew, K.; Seyfe, S.; Tuyiringire, N.; Peter, E. L.; Muluye, R. A.; Tolo, C. U.; Ogwang, P. E.
Efficacy and safety of cinnamon in type 2 diabetes mellitus and pre-diabetes patients: A meta-analysis and
meta-regression. Diabetes Res. Clin. Pract. 2019, 156, 107815. doi: 10.1016/j.diabres.2019.107815
Dhanabal, S. P.; Kumaradoss, M.; Maruga, M. Pharmacognostical, Antidiabetic and Antioxidant Studies on.
December. 2018.
Duarte, A. M.; Guarino, M. P.; Barroso, S.; Gil, M. M. Phytopharmacological strategies in the management of
type 2 diabetes mellitus. In: Foods (Vol. 9, Issue 3). 2020, doi: 10.3390/foods9030271
Eidi, A.; Eidi, M.; Esmaeili, E. Antidiabetic effect of garlic (Allium sativum L.) in normal and streptozotocin-
induced diabetic rats. Phytomedicine. 2006, 13(9–10), 624–629. doi: 10.1016/j.phymed.2005.09.010
El Gayar, M. H.; Aboromia, M. M. M.; Ibrahim, N. A.; Abdel Hafiz, M. H. Effects of ginger powder
supplementation on glycemic status and lipid profile in newly diagnosed obese patients with type 2 diabetes
mellitus. Obes. Med. 2019, 14(2018), 100094. doi: 10.1016/j.obmed.2019.100094
El-Abhar, H. S.; Schaalan, M. F. Phytotherapy in diabetes: Review on potential mechanistic perspectives.
World J. Diabetes. 2014, 5(2), 176. doi: 10.4239/wjd.v5.i2.176
Elshater, A.-E. A.; Mohammed, H. A.; Al-Amgad, Z.; Ali, R. A. Potential of Aloe vera and amaryl in
amelioration of hyperglycemia correlated with streptozotocin induced diabetes. SVU- Int. J. Vet. Sci. Res.
2022, 5(4), 41–52. doi: 10.21608/svu.2022.149203.1213

277
Escandón-Rivera, S. M.; Mata, R.; Andrade-Cetto, A. Molecules isolated from Mexican hypoglycemic plants:
A review. Molecules 2020, 25(18), 1–33. doi: 10.3390/molecules25184145
Gao, X.; Li, B.; Jiang, H.; Liu, F.; Xu, D.; Liu, Z. Dioscorea opposita reverses dexamethasone induced insulin
resistance. Fitoterapia. 2007, 78(1), 12–15. doi: 10.1016/j.fitote.2006.09.015
Gautam, S.; Paithankar, V .; Vyas, J.; Wankhade, A. Berberine and its Relevance IN anti-Diabetic Activity. 2021,
11(2), 242–251. https://www.academia.edu/download/65858283/36.pdf
Ghosh, S.; Saha, S. Tinospora cordifolia: One plant, many roles. Anc. Sci. Life. 2012, 31(4), 151. doi: 10.4103/
0257-7941.107344
Goel, R.;Bhatia, D.; Gilani, S. J.; Katiyar, D. Medicinal plants as antidiabetics: A review. Int. Bull. Drug Res.
2012, 1(2), 100–107.
Golovinskaia, O.; Wang, C. K. The hypoglycemic potential of phenolics from functional foods and their
mechanisms. Food Sci. Hum. Wellness. 2023, 12(4), 986–1007. doi: 10.1016/j.fshw.2022.10.020
Gonzales, A. M.; Orlando, R. A. Curcumin and resveratrol inhibit nuclear factor-kappaB-mediated cytokine
expression in adipocytes. Nutr. Metab. (Lond.) 2008, 5, 17. https://doi.org/10.1186/1743-7075-5-17
González-Flores, D. Ingestion of Japanese plums (Prunus salicina Lindl. cv. Crimson Globe) increases the urinary
6-sulfatoxymelatonin and total antioxidant capacity levels in young. middle-aged and elderly humans: Nutritional
and functional characterization of their content. J. Food & Nutr . Res. 2011, 50(January 2011), 229–236. http://search.
ebscohost.com/login.aspx?direct=true&profile=ehost&scope=site&authtype=crawler&jrnl=13368672&AN=6
9859318&h=zPCKRcfGYf0CFqNn7gao70rHyIxNi/nICiToAOC5xTyf5vwnWzeZjr0hGzro5j3KsoNwT5B7g/
GxajZV/rALmw==&crl=c
Grace, M. H.; Ribnicky, D. M.; Kuhn, P.; Poulev, A.; Logendra, S.; Yousef, G. G.; Raskin, I.; Lila, M. A.
Hypoglycemic activity of a novel anthocyanin-rich formulation from lowbush blueberry, vaccinium
angustifolium aiton. Phytomedicine. 2009, 16(5), 406–415. doi: 10.1016/j.phymed.2009.02.018
Guo, J.; Li, L.; Pan, J.; Qiu, G.-Q.; Li, A.; Huang, G.; Xu, L. [Pharmacological mechanism of Semen Litchi on
antagonizing insulin resistance in rats with type 2 diabetes]. Zhong Yao Cai. 2004, 27(6), 435–438. https://
api.semanticscholar.org/CorpusID:28063784
Gupta, R. C.; Chang, D.; Nammi, S.; Bensoussan, A.; Bilinski, K.; Roufogalis, B. D. Interactions between
antidiabetic drugs and herbs: An overview of mechanisms of action and clinical implications. Diabetol.
Metab. Syndr. 2017, 9(1), 1–12. doi: 10.1186/s13098-017-0254-9
Haghani, F.; Arabnezhad, M. R.; Mohammadi, S.; Ghaffarian-Bahraman, A. Aloe vera and streptozotocin-
induced diabetes mellitus. Rev. Bras. Farmacogn. 2022, 32(2), 174–187. doi: 10.1007/s43450-022-00231-3
Grover, J. K.; Y adav , S.; V ats, V. Medicinal_plants_of_India_with_anti_diab. J. Ethnopharmacol. 2002, 81, 81–100.
Jiao, P.; Feng, B.; Li, Y.; He, Q.; Xu, H. Hepatic ERK activity plays a role in energy metabolism. Mol. Cell.
Endocrinol. 2013, 375(1–2), 157–166. doi: 10.1016/j.mce.2013.05.021
Jn, S.; Ps, C.; Vd, M.; Sk, J. Role of fenugreek (Trigonella foenum graecum) on in management of diabetes
disease. ~ 184 ~ J Pharmacogn. Phytochem. 2019, 8(4), 184–187. http://dx.doi.org/10.1100/2012/859892.
Kadam, R. A.; Dhumal, N. D.; Khyade, V. B. The mulberry, morus alba (L.): The medicinal herbal source for
human health. Int. J. Curr . Micr obiol. Appl. Sci. 2019, 8(04), 2941–2964. doi: 10.20546/ijcmas.2019.804.341
Kamble, H.; Kandhare, A. D.; Bodhankar, S.; Mohan, V.; Thakurdesai, P. Effect of low molecular weight
galactomannans from fenugreek seeds on animal models of diabetes mellitus. Biomed. Aging Pathol. 2013,
3(3), 145–151. doi: 10.1016/j.biomag.2013.06.002
Kanetkar, P.; Singhal, R.; Kamat, M. Gymnema sylvestre: A memoir. J. Clin. Biochem. Nutr. 2007, 41(2),
77–81. doi: 10.3164/jcbn.2007010
Kassaian, N.; Azad, L.; Kassaian, N. Effect of fenugreek seeds on blood glucose and lipid profiles in type 2
diabetic patients. Int. J. Vitam. Nutr. Res., 2009, 79(1), 34–39.
Khalil, O. A. Antidiabetic activity of Rosmarinus officinalis and its relationship with the antioxidant property.
Afr. J. Pharm. Pharmacol. 2012, 6(14). doi: 10.5897/ajpp12.162
Khan, A. R.; Mushtaq, N.; Fiaz, H.; Islam, Z. U. Antioxidative properties of spices and their impact on
postprandial blood glucose in humans. Adv. Life Sci. 2019, 7(1), 5–9.
Klajnert, B.; Przygodzki, T. Therapeutic applications of dendrimers. Postepy Biochem. 2003, 49(4), 290–297.
Klein, R.; Klein, B. E. K.; Moss, S. E.; Cruickshanks, K. J. The medical management of hyperglycemia over a
10-year period in people with diabetes. Diabetes Care. 1996, 19(7), 744–750. doi: 10.2337/diacare.19.7.744

278
Krishnasamy, G.; Muthusamy, K.; Chellappan, D. R.; Subbiah, N. Antidiabetic, antihyperlipidaemic, and
antioxidant activity of syzygium densiflorum fruits in streptozotocin and nicotinamide-induced diabetic rats.
Pharm. Biol. 2016, 54(9), 1716–1726. doi: 10.3109/13880209.2015.1125932
Kumar, A.; Goel, M. K.; Jain, R. B.; Khanna, P.; Chaudhary, V. India towards diabetes control: Key issues.
Australas. Med. J. 2013, 6(10), 524–531. doi: 10.4066/AMJ.2013.1791
Kumar, R.; Saha, P.; Lokare, P.; Datta, K.; Selvakumar, P.; Chourasia, A. Systemic review of ocimum sanctum
(Tulsi): Morphological characteristics, phytoconstituents and therapeutic applications. Int. J. Res. Appl. Sci.
Biotechnol. 2022, 9(2), 221–226. doi: 10.31033/ijrasb.9.2.15
Laha, S.; Paul, S. Gymnema sylvestre (Gurmar): A potent herb with anti-diabetic and antioxidant potential.
Phcog. J. 2019, 11(2), 201–206. doi: 10.5530/pj.2019.11.33
Lee, B. H.; Chen, C. H.; Hsu, Y. Y.; Chuang, P. T.; Shih, M. K.; Hsu, W. H. Polysaccharides obtained from
cordyceps militaris alleviate hyperglycemia by regulating gut microbiota in mice fed a high-fat/sucrose diet.
Foods. 2021, 10(8), 1870. doi: 10.3390/foods10081870
Lee, J.; Noh, S.; Lim, S.; Kim, B. Plant extracts for type 2 diabetes: From traditional medicine to modern drug
discovery. Antioxidants. 2021, 10(1), 1–42. doi: 10.3390/antiox10010081
Les, F.; Cásedas, G.; Gómez, C.; Moliner, C.; Valero, M. S.; López, V. The role of anthocyanins as antidiabetic
agents: From molecular mechanisms to in vivo and human studies. J. Physiol. Biochem. 2021, 77(1), 109–131.
doi: 10.1007/s13105-020-00739-z
Leung, L.; Birtwhistle, R.; Kotecha, J.; Hannah, S.; Cuthbertson, S. Anti-diabetic and hypoglycaemic effects
of Momordica charantia (bitter melon): A mini review. Br. J. Nutr. 2009, 102(12), 1703–1708. doi: 10.1017/
S0007114509992054
Li, J.; Liu, T.; Wang, L.; Guo, X.; Xu, T.; Wu, L.; Qin, L.; Sun, W. Antihyperglycemic and antihyperlipidemic
action of cinnamaldehyde in C57blks/j Db/db mice. J. Tradit. Chin. Med. 2012, 32(3), 446–452. doi: 10.1016/
s0254-6272(13)60053-9
Liu, C. M.; Ma, J. Q.; Sun, J. M.; Feng, Z. J.; Cheng, C.; Yang, W.; Jiang, H. Association of changes in
ER stress-mediated signaling pathway with lead-induced insulin resistance and apoptosis in rats and their
prevention by A-type dimeric epigallocatechin-3-gallate. Food Chem. Toxicol. 2017, 110(September),
325–332. doi: 10.1016/j.fct.2017.10.040
Liu, Y.; Zhang, H.; Dai, X.; Zhu, R.; Chen, B.; Xia, B.; Ye, Z.; Zhao, D.; Gao, S.; Orekhov, A. N.; Zhang, D.;
W ang, L.; Guo, S. A comprehensive review on the phytochemistry , pharmacokinetics, and antidiabetic effect
of Ginseng. Phytomedicine. 2021, 92, 153717. doi: 10.1016/j.phymed.2021.153717
Lopes, G.; Silva, M.; Vasconcelos, V. The pharmacological potential of cyanobacteria. The Pharmacological
Potential of Cyanobacteria. 2022, 57(October), 1–340. doi: 10.1016/B978-0-12-821491-6.00011-9
Ma, J.; Meng, X.; Liu, Y.; Yin, C.; Zhang, T.; Wang, P.; Park, Y. K.; Jung, H. W. Effects of a rhizome aqueous
extract of Dioscorea batatas and its bioactive compound, allantoin in high fat diet and streptozotocin-induced
diabetic mice and the regulation of liver, pancreas and skeletal muscle dysfunction. J. Ethnopharmacol.
2020, 259(February), 112926. doi: 10.1016/j.jep.2020.112926
Madiwalar, V. S.; Dwivedi, P. S. R.; Patil, A.; Gaonkar, S. M. N.; Kumbhar, V. J.; Khanal, P.; Patil, B. M. Ficus
benghalensis promotes the glucose uptake- Evidence with in silico and in vitro. J. Diabetes Metab. Disord.
2022, 21(1), 429–438. doi: 10.1007/s40200-022-00989-2
Magnuson, B.; Ekim, B.; Fingar, D. C. Regulation and function of ribosomal protein S6 kinase (S6K) within
mTOR signalling networks. Biochem. J. 2012, 441(1), 1–21. doi: 10.1042/BJ20110892
Manikandan, R.; Anand, A. V.; Kumar, S.; Pushpa. Phytochemical and in vitro antidiabetic activity of psidium
guajava leaves. Phcog. J. 2016, 8(4), 392–394. doi: 10.5530/pj.2016.4.13
Material, E. S.; Society, T. R.; Figure, S. Electronic Supplementary Material (ESI) for Food & Function. 2019,
361, 0–6.
Mohammadi, E.; Behnam, B.; Mohammadinejad, R.; Guest, P. C.; Simental-Mendía, L. E.; Sahebkar, A.
Antidiabetic properties of curcumin: Insights on new mechanisms. Adv . Exp. Med. Biol. 2021, 1291(August),
151–164. doi: 10.1007/978-3-030-56153-6_9
Muley, A.; Muley, P.; Shah, M. Coffee to reduce risk of type 2 diabetes? : A systematic review. Curr. Diabetes
Rev. 2012, 8(3), 162–168. doi: 10.2174/157339912800564016
Naimi, M.; Vlavcheski, F.; Shamshoum, H.; Tsiani, E. Rosemary extract as a potential anti-hyperglycemic
agent: Current evidence and future perspectives. Nutrients. 2017, 9(9), 1–19. doi: 10.3390/nu9090968

279
Nasser Singab, A.; Youssef, F. S. Medicinal plants with potential antidiabetic activity and their assessment.
Med. Aromat. Plants. 2014, 03(01), 1–12. doi: 10.4172/2167-0412.1000151
Noh, J. S.; Park, C. H.; Yokozawa, T. Treatment with oligonol, a low-molecular polyphenol derived from
lychee fruit, attenuates diabetes-induced hepatic damage through regulation of oxidative stress and lipid
metabolism. Br. J. Nutr. 2011, 106(7), 1013–1022. doi: 10.1017/S0007114511001322
Olatunde, A.; Mohammed, A.; Ibrahim, M. A.; Shuaibu, M. N. Influence of methoxylation on the anti-diabetic
activity of ρ-hydroxybenzaldehyde in type 2 diabetic rat model. In: Phytomedicine Plus (Vol. 1, Issue 1).
Elsevier B.V. 2021, doi: 10.1016/j.phyplu.2020.100003
Pathak, R.; Sharma, H. A review on medicinal uses of cinnamomum verum (Cinnamon). J. Drug Deliv. Ther.
2021, 11(6-S), 161–166. doi: 10.22270/jddt.v11i6-s.5145
Patole, V. C.; Awari, D.; Chaudhari, S. Resveratrol-loaded microsponge gel for wound healing: In vitro and in
vivo characterization. Turk. J. Pharm. Sci. 2023, 20(1), 23–34. doi: 10.4274/tjps.galenos.2022.93275
Paul, S. A review on ethno medicinal plants of southern parts of West Bengal with anti-diabetic potential. ~ 98
~ J. Med. Plants Stud. 2022, 10(4), 98–101. www.plantsjournal.com
Poli, V.; Aparna, Y.; Reddy Motireddy, S. 6-Gingerol, new insights into its anti-diabetic potential with special
reference to AMPK pathway: A review. J. Food Nutr Res. 2022, 10(10), 681–695. doi: 10.12691/jfnr-10-10-6
Poolsup, N.; Suksomboon, N.; Kurnianta, P. D. M.; Deawjaroen, K. Effects of curcumin on glycemic control
and lipid profile in prediabetes and type 2 diabetes mellitus: A systematic review and meta-analysis. PLoS
One. 2019, 14(4), 1–18. doi: 10.1371/journal.pone.0215840
Puri, D.; Prabhu, K.; Murthy, P. Mechanism of action of a hypoglycemic principle isolated from fenugreek
seeds. J. Physiol. Pharmacol. 2002, 46, 457–462.
Qin, B.; Panickar, K. S.; Anderson, R. A. Cinnamon: Potential role in the prevention of insulin resistance,
metabolic syndrome, and type 2 diabetes. J. Diabetes Sci. T echnol. 2010, 4(3), 685–693. doi: 10.1177/19322968
1000400324
Rajagopal, K.; Sasikala, K. Antihyperglycaemic and antihyperlipidaemic effects of nymphaea stellata in
alloxan-induced diabetic rats. Singapore Med. J. 2008, 49(2), 137–141.
Sabet, F.; Asgary, S.; Rahimi, P.; Mahzouni, P.; Madani, H. Antidiabetic effect of hydroalcoholic extract of
Carthamus tinctorius L. in alloxan-induced diabetic rats. J. Res. Med. Sci. 2012, 17(6), 386–392.
Said, A.; Ross, M.; Trout, K.; Zhang, J. Simulation of surface water for un-gauged areas with storage-attenuation
wetlands. J. Am. Water Resour. Assoc. 2007, 43(2), 546–556. doi: 10.1111/j.1752-1688.2007.00043.x
Sarah, W .; Gojka, R.; Sicree, R.; Hilary King, A. G. Estimates for the year 2000 and projections for 2030. World
Health. 2004, 27(5), 1047–1053.
Sayago, C.; Camargo, V.; Barbosa, F.; Gularte, C.; Pereira, G.; Miotto, S.; Cechinel Filho, V.; Luiz Puntel, R.;
Folmer, V.; Mendez, A. Chemical composition and in vitro antioxidant activity of hydro-ethanolic extracts
from Bauhinia forficata subsp. pruinosa and B. variegata. Acta Biol. Hung. 2013, 64(1), 21–33. doi: 10.1556/
ABiol.64.2013.1.3
Semwal, D. K.; Kumar, A.; Aswal, S.; Chauhan, A.; Semwal, R. B. Protective and therapeutic effects of
natural products against diabetes mellitus via regenerating pancreatic β-cells and restoring their dysfunction.
Phytother. Res. 2021, 35(3), 1218–1229. doi: 10.1002/ptr.6885
Sharma, N.; Soni, R.; Sharma, M.; Chatterjee, S.; Parihar, N.; Mukarram, M.; kale, R.; Sayyed, A. A.; Behera,
S. K.; Khairnar, A. Chlorogenic acid: A polyphenol from coffee rendered neuroprotection against rotenone-
induced Parkinson’s disease by GLP-1 secretion. Mol. Neurobiol
s12035-022-03005-z
Sivakumar, T.; Deepa, B. A critical review on antidiabetic potential of herbal plants and its their bioactive
components. J. Univ. Shanghai Sci. Technol. 2023, 25(1), 303–314. doi: 10.51201/JUSST/23/0141
Soares, J. C. M.; Costa, S. T. da; Cecim, M. Níveis glicêmicos e de colesterol em ratos com Diabetes Mellitus
aloxano induzido, tratados com infusão de Bauhinia candicans ou syzygium jambolanum. Cienc. Rural.
2000, 30(1), 113–118. doi: 10.1590/s0103-84782000000100018
Sridhar, S N C; Sengupta, P.; Palawat, S.; P. S, D.; George, G.; Paul, A. T. Synthesis, molecular modelling, in
vitro and in vivo evaluation of conophylline inspired novel benzyloxy substituted indole glyoxylamides as
potent pancreatic lipase inhibitors. J. Biomol. Struct. Dyn. 2022, 40(19), 9530–9542. doi: 10.1080/07391102.
2021.1930168
. 2022, 59(11), 6834–6856. doi: 10.1007/

280
Stote, K. S.; Wilson, M. M.; Hallenbeck, D.; Thomas, K.; Rourke, J. M.; Sweeney , M. I.; Gottschall-Pass, K. T.;
Gosmanov, A. R. Effect of blueberry consumption on cardiometabolic health parameters in men with type 2
diabetes: An 8-week, double-blind, randomized, placebo-controlled trial. Curr. Dev. Nutr. 2020, 4(4), 1–10.
doi: 10.1093/CDN/NZAA030
Takahashi, T.; Miyazawa, M. Potent α-glucosidase inhibitors from safflower (Carthamus tinctorius L.) seed.
Phytother. Res. 2012, 26(5), 722–726. doi: 10.1002/ptr.3622
Upendra Rao, M.; Sreenivasulu, M.; Chengaiah, B.; Jaganmohan Reddy, K.; Madhusudhana Chetty, C. Herbal
medicines for diabetes mellitus: A review. Int. J. Pharmtech Res. 2010, 2(3), 1883–1892.
van Dam, R. M.; Willett, W. C.; Manson, J. E.; Hu, F . B. Cof fee, caf feine, and risk of type 2 diabetes. Diabetes
Care. 2006, 29(2), 398–403. doi: 10.2337/diacare.29.02.06.dc05-1512
Vo, T. S.; Vo, T. T. B. C.; Vo, T. T. T. N. Coffee: Health effects and various disease treatments. Food Health.
2022, 8(4), 344–358. doi: 10.3153/fh22032
Wankhede, S.; Mohan, V.; Thakurdesai, P. Beneficial effects of fenugreek glycoside supplementation in male
subjects during resistance training: A randomized controlled pilot study. J. Sport Health Sci. 2016, 5(2),
176–182. doi: 10.1016/j.jshs.2014.09.005
Wojcik, M.; Krawczyk, M.; Wozniak, L. A. Antidiabetic activity of curcumin. In: Nutritional and Therapeutic
Interventions for Diabetes and Metabolic Syndrome. 2nd edn. Elsevier Inc. 2018, doi: 10.1016/
B978-0-12-812019-4.00031-3
Wojcik, M.; Krawczyk, M.; Wojcik, P.; Cypryk, K.; Wozniak, L. A. Molecular mechanisms underlying
curcumin-mediated therapeutic effects in type 2 diabetes and cancer. Oxid. Med. Cell. Longev. 2018, 2018,
9698258. doi: 10.1155/2018/9698258
Wu, F.; Chen, X. [A review of pharmacological study on Astragalus membranaceus (Fisch.) Bge]. Zhong Yao
Cai. 2004, 27(3), 232–234.
Yang, H. J.; Kim, M. J.; Kwon, D. Y.; Kim, D. S.; Lee, Y. H.; Kim, J. E.; Park, S. Anti-diabetic activities of
gastrodia elata blume water extracts are mediated mainly by potentiating glucose-stimulated insulin secretion and
increasing β-cell mass in non-obese type 2 diabetic animals. Nutrients. 2016, 8(3), 161. doi: 10.3390/nu8030161
Yaribeygi, H.; Katsiki, N.; Behnam, B.; Iranpanah, H.; Sahebkar, A. MicroRNAs and type 2 diabetes mellitus:
Molecular mechanisms and the effect of antidiabetic drug treatment. Metab. Clin. Exp. 2018, 87, 48–55. doi:
10.1016/j.metabol.2018.07.001
Y oung, S. N. How to increase serotonin in the human brain without drugs. J. Psych. Neurosci. 2007, 32(6), 394–399.
Yuan, C.-S.; Bieber, E. J. Textbook of Complementary and Alternative Medicine. CRC Press. 2003.
Zhao, M.; Zhang, Z. F.; Ding, Y.; Wang, J. B.; Li, Y. Astragalus polysaccharide improves palmitate-induced
insulin resistance by inhibiting PTP1B and NF-κB in C2C12 myotubes. Mol. 2012, 17(6), 7083–7092. doi:
10.3390/molecules17067083
Zheng, J.; Cheng, J.; Zheng, S.; Feng, Q.; Xiao, X. Curcumin, a polyphenolic curcuminoid with its protective
effects and molecular mechanisms in diabetes and diabetic cardiomyopathy. Front. Pharmacol. 2018,
9(MAY), 1–10. doi: 10.3389/fphar.2018.00472
Zheng, Y.; Ren, W.; Zhang, L.; Zhang, Y.; Liu, D.; Liu, Y. A review of the pharmacological action of astragalus
polysaccharide. Front. Pharmacol. 2020, 11(March), 1–15. doi: 10.3389/fphar.2020.00349

CHAPTER 13
Marine-Derived Natural Products with Anticancer Properties
POPAT MOHITE
1
2
3
1,*
, RAMDAS PANDHARE2, and DESHRAJ CHUMBHALE
3
*Corresponding author
ABSTRACT
In recent years, marine environments have emerged as promising sources of bioactive
compounds with potent anticancer properties. Marine organisms, such as sponges, corals,
mollusks, algae, and bacteria, have been found to produce a plethora of natural products
exhibiting remarkable cytotoxicity against various cancer cell lines. This chapter highlights the diversity and sources of marine-derived natural products with proven anticancer
potential. It also emphasizes the various strategies employed in the isolation, identification,
and characterization of bioactive compounds from marine sources. The chemical structures, mechanisms of action, and preclinical and clinical studies of marine-derived natural
products including alkaloids, terpenoids, peptides, polyketides, and steroids are described
in detail. Furthermore, the limitations associated with the development of marine-derived
natural products as anticancer drugs, including the need for sustainable collection methods,
synthetic analogs for structure–activity relationship studies, and overcoming issues related
to bioavailability and toxicity, are addressed. Strategies to enhance the production and
supply of these compounds through biotechnology and synthetic biology approaches are
also discussed. In conclusion, marine-derived natural products represent a valuable source
of anticancer agents with diverse chemical structures and mechanisms of action. Continued
research in this field, holds promise for the future discovery and development of marinederived anticancer drugs.
13.1 INTRODUCTION
In recent years, most of the lead compounds that have been shown to be useful in a wide
range of pharmacological applications come from marine sources. It is noteworthy that

282
marine microorganisms are still the source of a significant number of essential bioactive
compounds, although not many people are aware of this fact. There are microorganisms
living in a broad variety of environments, ranging from the fine sand on a beach to the
enormous ocean, which accounts for the majority of the earth’s biosphere. Microbes,
especially those that reside in water, are able to survive in environments with high
temperatures, high pressures, and incredible quantities of food. The therapeutic efficacy
of biological materials derived from natural sources is evaluated with the use of highthroughput screening methods to facilitate the development of a method or product that
is economically more viable. One of the greatest environments for bio-prospecting is
marine habitat because it has a high number of microorganisms that have not yet been
investigated. Microbes are very excellent at recognizing, responding, and adapting to
their surroundings. To survive and thrive in their environment, they produce various
secondary metabolites. Both biotechnology and medicine have made use of compounds
that are produced under stress by organisms (Karthikeyan et al., 2022). There are still
many bioactive molecules in the marine environment which are a promising source
of nutraceuticals and functional foods. Many studies have used biotechnology to find
and synthesize novel substances with the goal of expanding the variety of important
chemicals already found in the ocean and making them more accessible. When compared
to other biological reserves, ocean has received surprisingly less attention. It is the
home to a diverse array of species, each of which has its own set of unique biological
characteristics. It has been reported that algae and microalgae are an affluent source
of bioactive chemicals that may be used in the preparation of nutritionally beneficial
meals. Compounds derived from marine animals are particularly intriguing because of
the fluctuations in salt, temperature, and light which occur as a natural aspect of marine
atmosphere. Quantity and variety of marine functional components might increase by
increasing the number of studies into locating and creating marine chemicals employing
biotechnology. Marine bio-resources are responsible for the production of bioactive
substances such as enzymes, peptides, proteins, phenolic compounds, polysaccharides,
and fatty acids. These compounds have a relatively narrow use and a high level of
potency. Proteins derived from marine sources include beneficial components of diets
due to the myriad of fascinating and one-of-a-kind features that they possess. These
properties include the capacity to produce gels and foams, as well as the ability to
operate as an antibacterial agent. Phenolic compounds are an appealing candidate for
usage in a variety of biotechnological contexts. One of the most promising sites to
look for naturally occurring bioactive metabolites that are safe for the environment
is in microalgae. Microalgae are living creatures that produce food by using light as
an energy source. These are aquatic organisms that produce fatty acids, carotenoid
pigments, and phenolic compounds (Avila and Angulo-Preckler, 2020).
13.2 MARINE BIOACTIVE COMPOUNDS
The development of antibiotic resistance in microorganisms is an issue that threatens
the health of people all over the world. There is an urgent need for the development of
Соседние файлы в папке Библиотека им академика М.И. Перельмана
